Position in GRAL
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$6,153,279
-$3,507,178 QoQ
Shares Held
119,065
+5.5% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $53,854,611 across 8 Diagnostics & Research names. GRAL ranks #2 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
211,308 | $40,063,996 | |
| 2 | GRAL |
GRAIL, Inc.
This page
|
119,065 | $6,153,279 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
9,072 | $4,459,160 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
757 | $954,728 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,658 | $931,613 | |
| 6 | WAT |
Waters Corp /De/
|
1,621 | $482,733 | |
| 7 | RVTY |
Revvity, Inc.
|
5,030 | $440,678 | |
| 8 | ILMN |
Illumina, Inc.
|
2,989 | $368,424 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,153,279 | 119,065 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,660,457 | 112,869 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $7,131,137 | 120,601 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,566,472 | 108,255 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $2,639,891 | 103,363 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,784,268 | 99,959 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,000,269 | 72,694 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||